+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Proteasome Inhibitor"

Proteasome Inhibitors Global Market Report 2024 - Product Thumbnail Image

Proteasome Inhibitors Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Global Proteasome Inhibitors Market 2024-2028 - Product Thumbnail Image

Global Proteasome Inhibitors Market 2024-2028

  • Report
  • December 2023
  • 173 Pages
  • Global
From
Generic Oncology Drugs Global Market Report 2024 - Product Thumbnail Image

Generic Oncology Drugs Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
From
CAR T - Cell Therapy - Competitive landscape, 2023 - Product Thumbnail Image

CAR T - Cell Therapy - Competitive landscape, 2023

  • Report
  • April 2023
  • 500 Pages
  • Global
From
From
Precision Cancer Therapeutics, 2022 - Product Thumbnail Image

Precision Cancer Therapeutics, 2022

  • Report
  • November 2022
  • 154 Pages
  • Global
From
From
Blood Cancer Therapeutics: Global Markets to 2023 - Product Thumbnail Image

Blood Cancer Therapeutics: Global Markets to 2023

  • Report
  • December 2018
  • 174 Pages
  • Global
From
Proteasome inhibitors - Pipeline Insight, 2022 - Product Thumbnail Image

Proteasome inhibitors - Pipeline Insight, 2022

  • Clinical Trials
  • January 2022
  • 60 Pages
  • Global
From
20s Proteasome Inhibitor - Pipeline Insight, 2022 - Product Thumbnail Image

20s Proteasome Inhibitor - Pipeline Insight, 2022

  • Clinical Trials
  • January 2022
  • 90 Pages
  • Global
From
Selinexor - Product Thumbnail Image

Selinexor

  • Report
  • October 2018
  • 32 Pages
  • Global
From
20s Proteasome - Pipeline Review, H2 2020 - Product Thumbnail Image

20s Proteasome - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 78 Pages
  • Global
From
From
Drug Delivery in Cancer - Technologies, Markets & Companies - Product Thumbnail Image

Drug Delivery in Cancer - Technologies, Markets & Companies

  • Report
  • November 2021
  • 747 Pages
  • Global
From
Loading Indicator

The Proteasome Inhibitor market within the context of Oncology Drugs is a rapidly growing field of research and development. Proteasome inhibitors are drugs that target the proteasome, a cellular structure responsible for the breakdown of proteins. These drugs are used to treat a variety of cancers, including multiple myeloma, lymphoma, and other solid tumors. Proteasome inhibitors have been shown to be effective in treating these cancers, and have become an important part of the oncology drug market. The Proteasome Inhibitor market is highly competitive, with many companies developing and marketing their own drugs. Some of the major players in the market include Bristol-Myers Squibb, Merck, Novartis, Pfizer, and Takeda. Other companies such as Celgene, Johnson & Johnson, and AstraZeneca are also involved in the development and marketing of proteasome inhibitors. Show Less Read more